Director William H. Milliken was quoted in the article “High Court Patent Review Ruling Helps Agency Head Shape Results,” published by Bloomberg Law. He commented on the US Supreme Court’s decision in United States v. Arthrex, Inc. that was issued on June 21, 2021. From the article:

“Not only do the judges get their job security back but they also won’t have to rehear the hundreds of cases left in limbo. The Federal Circuit has vacated many decisions the board made before Arthrex and remanded them to be reconsidered by a new panel of judges.

The ruling makes those rehearings unnecessary, according to Sterne Kessler Goldstein & Fox PLLC attorney William Milliken. Instead, ‘it seems clear what is necessary, at least in cases where the challenge is preserved, is that the director have an opportunity to rehear the petition,’ he said.”